Qure.ai key facts
as of Oct 2026- Developer of an automated interpretation technology designed to make healthcare affordable and accessible.
- Qure.ai is valued at approximately $231.0M as of Oct 2026 (last reported valuation).
- It has raised $156.5M; the latest was Later Stage VC in Oct 2025.
- Notable investors include Peak XV Partners, General Atlantic, AI Venture Labs, Novo Holdings, MassMutual Ventures — 18 tracked in total.
- Status: Privately Held (backing).
Qure.ai's last reported valuation, Sep 2024. Nothing priced has surfaced since.
- ·The complete investor list: 18 names
- ·Watch Qure.ai: the Monday email on marks, rounds and moves
Qure.ai funding rounds
No funding rounds for Qure.ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Qure.ai
18+Qure.ai valuation
Qure.ai's last reported valuation was $231 million in Sep 2024. No priced round, secondary trade or fund mark has surfaced since.
Qure.ai investors
18 investors are on record for Qure.ai, including Peak XV Partners, General Atlantic, AI Venture Labs and Novo Holdings. By type, the record holds 5 venture capital firms and 1 growth equity firm.
About Qure.ai
Developer of an automated interpretation technology designed to make healthcare affordable and accessible. The company's tech utilizes artificial intelligence and algorithms for classifying radiology images as normal or abnormal, diagnosing disease and highlighting abnormalities that may otherwise be overlooked, enabling doctors to diagnose diseases and highlight abnormalities more accurately.
- Sector
- Healthcare
- HQ
- Mumbai, India
- Founded
- 2016
- Employees
- 163
- Website
- qure.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.